NovaBay Pharmaceuticals, Inc. — Investor Relations & Filings
Filings indexed
1,024
across all filing types
Latest filing
2026-04-29
Annual Report
Country
US
United States of America
Listing
US
NBY
NovaBay Pharmaceuticals, Inc. is a biopharmaceutical company that develops and commercializes scientifically-created and clinically-proven products for the eyecare, skincare, and wound care markets. The company's core technology is a proprietary, stable formulation of hypochlorous acid. Its leading product is Avenova®, an antimicrobial lid and lash solution available over-the-counter for eye hygiene. In the wound care sector, NovaBay manufactures and sells products under the NeutroPhase® and PhaseOne® brands, which utilize its hypochlorous acid technology to aid in cleansing and debridement. The company focuses on providing accessible, problem-solving solutions for improved well-being.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 10-K/A - Stablecoin Development Corp (0001389545) (Filer) | 2026-04-29 | English | |
| 8-K - Stablecoin Development Corp (0001389545) (Filer) | 2026-04-06 | English | |
| 8-K - Stablecoin Development Corp (0001389545) (Filer) | 2026-04-01 | English | |
| 8-K - NovaBay Pharmaceuticals, Inc. (0001389545) (Filer) | 2026-03-23 | English | |
| 10-K - NovaBay Pharmaceuticals, Inc. (0001389545) (Filer) | 2026-03-19 | English | |
| 8-K - NOVABAY PHARMACEUTICALS, INC. (0001389545) (Filer) | 2026-02-20 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 38830554 | 10-K/A - Stablecoin Development Corp (0001389545) (Filer) | 2026-04-29 | English | ||
| 33600256 | 8-K - Stablecoin Development Corp (0001389545) (Filer) | 2026-04-06 | English | ||
| 33149953 | 8-K - Stablecoin Development Corp (0001389545) (Filer) | 2026-04-01 | English | ||
| 33013388 | 8-K - NovaBay Pharmaceuticals, Inc. (0001389545) (Filer) | 2026-03-23 | English | ||
| 32989688 | 10-K - NovaBay Pharmaceuticals, Inc. (0001389545) (Filer) | 2026-03-19 | English | ||
| 32891097 | 8-K - NOVABAY PHARMACEUTICALS, INC. (0001389545) (Filer) | 2026-02-20 | English | ||
| 32891098 | 8-K - NOVABAY PHARMACEUTICALS, INC. (0001389545) (Filer) | 2026-02-12 | English | ||
| 29306244 | DEF 14A Filing | 2026-02-10 | English | ||
| 29306174 | 8-K Filing | 2026-01-30 | English | ||
| 29306250 | SCHEDULE 13D/A Filing | 2026-01-29 | English | ||
| 29306204 | 4 Filing | 2026-01-29 | English | ||
| 29306223 | 8-K Filing | 2026-01-28 | English | ||
| 29306176 | D Filing | 2026-01-27 | English | ||
| 29306227 | SCHEDULE 13D/A Filing | 2026-01-21 | English | ||
| 29306153 | SCHEDULE 13D/A Filing | 2026-01-21 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
NovaBay Pharmaceuticals, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/35098/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=35098 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=35098 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=35098 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 35098}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for NovaBay Pharmaceuticals, Inc. (id: 35098)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.